Literature DB >> 19687338

Vasomotor symptoms, adoption of a low-fat dietary pattern, and risk of invasive breast cancer: a secondary analysis of the Women's Health Initiative randomized controlled dietary modification trial.

Bette J Caan1, Aaron Aragaki, Cynthia A Thomson, Marcia L Stefanick, Rowan Chlebowski, F Allan Hubbell, Lesley Tinker, Mara Vitolins, Aleksandar Rajkovic, Maria Bueche, Judy Ockene.   

Abstract

PURPOSE: To assess whether the effect of a low-fat dietary pattern on breast cancer incidence varied by report of baseline vasomotor symptoms.
METHODS: Postmenopausal women age 50 to 79 years enrolled onto the Women's Health Initiative (WHI) Dietary Modification trial from 1993 to 1998 were randomly assigned to a low-fat dietary intervention (n = 19,541) or comparison (n = 29,294). Presence of vasomotor symptoms at baseline was ascertained from a 34-item self-report symptom inventory. Women were queried semi-annually for a new diagnosis of breast cancer. Each case report was verified by medical record and pathology report review by centrally trained WHI physician adjudicators.
RESULTS: Among participants who reported hot flashes (HFs) at baseline (n = 3,375), those assigned to the low-fat diet had a breast cancer rate of 0.27 compared with their counterparts in the control group who had a rate of 0.41 (hazard ratio [HR] = 0.65; 95% CI, 0.42 to 1.01). Among women reporting no HFs (n = 45,160), the breast cancer rate was 0.42 in those assigned to the low-fat diet compared with 0.46 in the control group (HR = 0.93; 95% CI, 0.84 to 1.03; P for interaction = .12 by HF status). Furthermore, the dietary benefits observed seemed to be specific to estrogen receptor (ER) -positive/progesterone receptor (PR) -positive tumors (ER positive/PR positive v other, P for risk = .03). Although women with and without HFs differed with regard to breast cancer risk factors, the effect of the diet intervention on breast cancer incidence by HF status was consistent across risk factor strata.
CONCLUSION: The results of this trial, which are hypothesis generating, suggest that HFs may identify a subgroup of postmenopausal women whose risk of invasive breast cancer might be reduced with the adoption of a low-fat eating pattern.

Entities:  

Mesh:

Year:  2009        PMID: 19687338      PMCID: PMC2754902          DOI: 10.1200/JCO.2008.20.0493

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  22 in total

1.  Feasibility and psychometrics of an ambulatory hot flash monitoring device.

Authors:  J S Carpenter; M A Andrykowski; R R Freedman; R Munn
Journal:  Menopause       Date:  1999       Impact factor: 2.953

2.  Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women.

Authors:  Teresa T Fung; Frank B Hu; Marjorie L McCullough; P K Newby; Walter C Willett; Michelle D Holmes
Journal:  J Nutr       Date:  2006-02       Impact factor: 4.798

3.  Dietary patterns and survival after breast cancer diagnosis.

Authors:  Candyce H Kroenke; Teresa T Fung; Frank B Hu; Michelle D Holmes
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

4.  Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.

Authors:  Matthew P Goetz; James M Rae; Vera J Suman; Stephanie L Safgren; Matthew M Ames; Daniel W Visscher; Carol Reynolds; Fergus J Couch; Wilma L Lingle; David A Flockhart; Zeruesenay Desta; Edith A Perez; James N Ingle
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

5.  Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.

Authors:  José M Aldrighi; Deborah C Quail; Jacques Levy-Frebault; Fernanda Aguas; Kurt Kosian; Lurdes Garrido; Brigitte Bosio-Le Goux; Max Saráchaga; Alice Graebe; Antonio J Niño; Thomas Nickelsen
Journal:  Am J Obstet Gynecol       Date:  2004-12       Impact factor: 8.661

6.  Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial.

Authors:  Ellen B Gold; John P Pierce; Loki Natarajan; Marcia L Stefanick; Gail A Laughlin; Bette J Caan; Shirley W Flatt; Jennifer A Emond; Nazmus Saquib; Lisa Madlensky; Sheila Kealey; Linda Wasserman; Cynthia A Thomson; Cheryl L Rock; Barbara A Parker; Njeri Karanja; Vicky Jones; Richard A Hajek; Minya Pu; Joanne E Mortimer
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

7.  Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. The Women's Health Trial Study Group.

Authors:  R Prentice; D Thompson; C Clifford; S Gorbach; B Goldin; D Byar
Journal:  J Natl Cancer Inst       Date:  1990-01-17       Impact factor: 13.506

8.  Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer.

Authors:  Cheryl L Rock; Shirley W Flatt; Cynthia A Thomson; Marcia L Stefanick; Vicky A Newman; Lovell A Jones; Loki Natarajan; Cheryl Ritenbaugh; Kathryn A Hollenbach; John P Pierce; R Jeffrey Chang
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

9.  The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients.

Authors:  D P Rose; J M Connolly; R T Chlebowski; I M Buzzard; E L Wynder
Journal:  Breast Cancer Res Treat       Date:  1993-09       Impact factor: 4.872

10.  Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.

Authors:  Ross L Prentice; Bette Caan; Rowan T Chlebowski; Ruth Patterson; Lewis H Kuller; Judith K Ockene; Karen L Margolis; Marian C Limacher; JoAnn E Manson; Linda M Parker; Electra Paskett; Lawrence Phillips; John Robbins; Jacques E Rossouw; Gloria E Sarto; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Linda Van Horn; Mara Z Vitolins; Jean Wactawski-Wende; Robert B Wallace; Sylvia Wassertheil-Smoller; Evelyn Whitlock; Katsuhiko Yano; Lucile Adams-Campbell; Garnet L Anderson; Annlouise R Assaf; Shirley A A Beresford; Henry R Black; Robert L Brunner; Robert G Brzyski; Leslie Ford; Margery Gass; Jennifer Hays; David Heber; Gerardo Heiss; Susan L Hendrix; Judith Hsia; F Allan Hubbell; Rebecca D Jackson; Karen C Johnson; Jane Morley Kotchen; Andrea Z LaCroix; Dorothy S Lane; Robert D Langer; Norman L Lasser; Maureen M Henderson
Journal:  JAMA       Date:  2006-02-08       Impact factor: 56.272

View more
  2 in total

1.  Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population.

Authors:  Aruna Kamineni; Melissa L Anderson; Emily White; Stephen H Taplin; Peggy Porter; Rachel Ballard-Barbash; Kathleen Malone; Diana S M Buist
Journal:  Cancer Causes Control       Date:  2012-12-07       Impact factor: 2.506

2.  Establishing a program for individuals at high risk for breast cancer.

Authors:  Fernando Cadiz; Henry M Kuerer; Julio Puga; Jamile Camacho; Eduardo Cunill; Banu Arun
Journal:  J Cancer       Date:  2013-07-01       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.